Biogen Inc. (BIIB) - Get Report is expected to report adjusted net income of $1.5 billion, or $8.28 a share, on sales of $3.5 billion before the market opens on Tuesday, based on a FactSet survey of 25 analysts.
In the same period a year ago, the company posted earnings of $7.40 a share on sales of $3.4 billion. It reported net income of $866.6 million.
The stock has fallen 9.8% since the company last reported earnings on July 23.
Quarterly estimates have risen 5.3 cents a share in the past month.
In the upcoming quarter, analysts are forecasting adjusted net income of $1.5 billion, or $7.98 a share, on sales of $3.5 billion.
Biogen is currently trading at a price-to-forward-earnings ratio of 6.9 based on the 12-month estimates of 27 analysts surveyed by FactSet.
Jim Cramer and the Action Alerts Plus team are watching the Biotechnology sector. To find out more about what stocks they like in the industry click here now to get more from Action Alerts PLUS.
Save 57% during our Halloween Sale. Don't let this market haunt you. Join Jim Cramer's Investment Club, Action Alerts PLUS. Click here to sign up!